We treat all patients with hematological disorders, including hematopoietic malignant diseases such as leukemia, malignant lymphoma, myelodysplastic syndromes, and multiple myeloma, as well as anemia and hemostatic disorders. We are committed to providing the medical care services most appropriate for individual patients collaboratively with a team of physicians of various clinical sections, with respect for patient's rights, centering on the usual chemotherapy regimen, molecular target medication, radioimmunotherapy, and hematopoietic stem cell transplantation. We always strive to select the optimal treatment for individual cases based on the latest evidence. New examination techniques are used in daily consultation; moreover, clinical studies on new drugs are proactively conducted to provide up-to-date medical care services.
At present, about 200 patients, most of whom suffer from hematopoietic malignant diseases, are admitted annually. Among these inpatients, those with refractory disease and/or poor outcome undergo related bone marrow transplantation or unrelated hematopoietic stem cell transplantation with the assistance of the Japan Marrow Donor Program (JMDP). We also have abundant experience in the diagnosis and treatment of idiopathic thrombocytopenic purpura among hemorrhagic diseases, and accept a lot of patients referred from other medical facilities.